We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
-12.28%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$334B
AUM Growth
-$65.4B
Cap. Flow
-$11.7B
Cap. Flow %
-3.51%
Top 10 Hldgs %
13.97%
Holding
7,016
New
146
Increased
2,663
Reduced
3,412
Closed
209

Sector Composition

Rank Sector Weight
1 Technology 12.53%
2 Healthcare 10.36%
3 Financials 9.14%
4 Consumer Discretionary 7.65%
5 Communication Services 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTX
6176
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$4K ﹤0.01%
10,782
+8,711
+421% +$5.42K
EMMS
6177
DELISTED
Emmis Communications Corp
EMMS
$4K ﹤0.01%
1,389
-521
-27% -$2.01K
OHAI
6178
DELISTED
OHA Investment Corporation
OHAI
$4K ﹤0.01%
3,916
GSP
6179
DELISTED
Barclays Bank PLC iPath Exchange Traded Notes due 2036 Linked to GSCI Total Return Index
GSP
$4K ﹤0.01%
328
MORL
6180
DELISTED
ETRACS Monthly Pay 2xLeveraged Mortgage REIT ETN
MORL
$4K ﹤0.01%
+319
New +$4.56K
SPHS
6181
DELISTED
Sophiris Bio, Inc.
SPHS
$4K ﹤0.01%
5,000
OMED
6182
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$4K ﹤0.01%
5,864
-7,058
-55% -$10.6K
SZO
6183
DELISTED
DB Crude Oil Short Exchange Traded Notes due June 1, 2038
SZO
$4K ﹤0.01%
50
OLO
6184
DELISTED
DB Crude Oil Long Exchange Traded Notes due June 1, 2038
OLO
$4K ﹤0.01%
1,000
ADIL
6185
Adial Pharmaceuticals
ADIL
$7.31M
$3K ﹤0.01%
1
ATOM icon
6186
Atomera
ATOM
$200M
$3K ﹤0.01%
1,032
+832
+416% +$3.3K
CLRO icon
6187
ClearOne Inc
CLRO
$10.9M
$3K ﹤0.01%
140
FALN icon
6188
iShares Fallen Angels USD Bond ETF
FALN
$1.63B
$3K ﹤0.01%
+109
New +$2.78K
FISK
6189
Empire State Realty OP LP Series 250
FISK
$1.42B
$3K ﹤0.01%
300
INTG icon
6190
InterGroup Corp
INTG
$61.1M
$3K ﹤0.01%
104
-282
-73% -$9.18K
KXIN icon
6191
Kaixin Holdings
KXIN
$8.76M
0
LEGR icon
6192
First Trust Indxx Innovative Transaction & Process ETF
LEGR
$131M
$3K ﹤0.01%
130
+30
+30% +$822
LGL icon
6193
LGL Group
LGL
$45.2M
$3K ﹤0.01%
1,273
-1,962
-61% -$4.82K
LGMK
6194
DELISTED
LogicMark
LGMK
$3K ﹤0.01%
1
LINC icon
6195
Lincoln Educational Services
LINC
$1.33B
$3K ﹤0.01%
976
-7
-0.7% -$17
LPCN icon
6196
Lipocine
LPCN
$17.5M
$3K ﹤0.01%
118
LWAY icon
6197
Lifeway Foods
LWAY
$455M
$3K ﹤0.01%
1,738
-1,139
-40% -$3.03K
NNVC icon
6198
NanoViricides
NNVC
$38.8M
$3K ﹤0.01%
693
+200
+41% +$1.28K
PRPH
6199
DELISTED
ProPhase Labs
PRPH
$3K ﹤0.01%
85
-1
-1% -$30
ROBT icon
6200
First Trust Nasdaq Artificial Intelligence and Robotics ETF
ROBT
$721M
$3K ﹤0.01%
100

Similar funds

Morgan Stanley's Q4 2018 Portfolio in Review

As of Q4 2018, Morgan Stanley held 7,016 positions worth $334B, down 16% from $400B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Morgan Stanley withdrew a net $11.7B in Q4 2018, closing 209 positions and reducing 3,412 holdings. Its most notable exit was Praxair Inc, an estimated $398M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Morgan Stanley opened a new position in Linde worth $342M.

  • Morgan Stanley's largest Q4 2018 buy was Linde: 2,188,871 shares worth $342M.
  • Morgan Stanley added most to People Inc in Q4 2018, an estimated $558M increase.
  • Morgan Stanley's biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
  • Morgan Stanley fully exited Praxair Inc in Q4 2018, selling an estimated $398M.
  • Morgan Stanley's ten largest holdings make up 14% of its $334B portfolio in Q4 2018.
  • Morgan Stanley opened 146 new positions and closed 209 in Q4 2018.
  • Morgan Stanley's portfolio value fell 16% quarter-over-quarter to $334B.

Based on Morgan Stanley's 13F filing for Q4 2018, filed 14 Feb 2019.